Edited Transcript of AGEN earnings conference call or presentation 4-Nov-19 1:30pm GMT [Yahoo! Finance News]
Agenus Inc. (AGEN)
Last agenus inc. earnings: 3/12 07:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
agenusbio.com/investors
Company Research
Source: Yahoo! Finance News
Edited Transcript of AGEN earnings conference call or presentation 4-Nov-19 1:30pm GMT As you can see from our IND chart, we have generated 13 immuno-oncology agents, which are all in clinical development presently. We expect that some of the next-generation agents in our pipeline can help expand the market opportunity for our PD-1 and our CTLA-4 antibodies. For example, to the extent that the combination of our next-gen CTLA-4 antibody plus our PD-1 antibody performs better than those in the market today, we believe our PD-1 commercial opportunity could be substantial. And on that note, we plan to start our combination trials for our next-gen CTLA-4 and our on own PD-1 antibodies this month. In addition to the leverage, our PD-1 and CTLA-4 antibodies provide us with, for our development strategy, we have been approached by several companies who have expressed their interest to access our agents to develop with their own proprietary products. And this has, of course, many advantages t
Show less
Read more
Impact Snapshot
Event Time:
AGEN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AGEN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AGEN alerts
High impacting Agenus Inc. news events
Weekly update
A roundup of the hottest topics
AGEN
News
- Agenus Regains Compliance with Nasdaq Minimum Bid Price Requirement [Yahoo! Finance]Yahoo! Finance
- Agenus Regains Compliance with Nasdaq Minimum Bid Price RequirementBusiness Wire
- Time Is Running Out For Agenus To Raise Cash [Seeking Alpha]Seeking Alpha
- Up 40%: Is This Red-Hot Growth Stock Still a Buy? [Yahoo! Finance]Yahoo! Finance
- Botensilimab/Balstilimab Data in MSS CRC Selected for the American Society of Clinical Oncology 2024 Annual Meeting [Yahoo! Finance]Yahoo! Finance
AGEN
Earnings
- 3/14/24 - Miss
AGEN
Analyst Actions
- 3/18/24 - HC Wainwright
AGEN
Sec Filings
- 4/26/24 - Form ARS
- 4/26/24 - Form DEF
- 4/22/24 - Form 4
- AGEN's page on the SEC website